PSMA4 and lung carcinoma: High IREB2 correlated with improved lung cancer prognosis (nonsignificant in LUSC), high PSMA4 expression correlates with poor prognosis in lung cancer overall but demonstrates a favorable association in LUAD patients​ (Figure 4C).